Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Journal of Experimental Therapeutics & Oncology|July 17, 2004
Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacyDinja Oosterhoff, Victor W van Beusechem
International Journal of Molecular Sciences|June 2, 2021
Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic OpportunitiesMaxime Blijlevens, Jing Li, Victor W van Beusechem
European Journal of Immunology|July 29, 2025
Immunological Impact of Oncolytic Adenoviruses On Cancer Therapy: Clinical InsightsReza Nadafi, Wenliang Dong, Victor W van Beusechem
Methods in Molecular Biology (Clifton, N.J.)|April 20, 2018
High-Throughput Firefly Luciferase Reporter AssaysEllen Siebring-van Olst, Victor W van Beusechem
Human Gene Therapy|January 25, 2017
Functional Screening Identifies Human miRNAs that Modulate Adenovirus Propagation in Prostate Cancer CellsJasmina Hodzic, Daoud Sie, Annaleen Vermeulen, et al.
Expert Opinion on Biological Therapy|May 12, 2015
Arming oncolytic viruses to leverage antitumor immunityTanja D de Gruijl, Axel B Janssen, Victor W van Beusechem
Molecular Cancer Therapeutics|June 16, 2005
Conditionally replicative adenovirus expressing degradation-resistant p53 for enhanced oncolysis of human cancer cells overexpressing murine double minute 2Victor W van Beusechem, Petra B van den Doel, Winald R Gerritsen
Human Gene Therapy|August 22, 2014
Changing faces in virology: the dutch shift from oncogenic to oncolytic virusesZineb Belcaid, Martine L M Lamfers, Victor W van Beusechem, et al.
BMC Medical Genomics|July 4, 2013
Analysis of small-sample clinical genomics studies using multi-parameter shrinkage: application to high-throughput RNA interference screeningMark A van de Wiel, Renée X de Menezes, Ellen Siebring-van Olst, et al.
Pageof 8